Ostertag Eric 4
4 · Poseida Therapeutics, Inc. · Filed Feb 3, 2023
Insider Transaction Report
Form 4
Ostertag Eric
DirectorChief Executive Officer10% Owner
Transactions
- Tax Payment
Common Stock
2023-02-01$7.00/sh−11,776$82,432→ 827,320 total
Holdings
- 3,659,503(indirect: See footnote)
Common Stock
- 961,445(indirect: See footnote)
Common Stock
- 580,292(indirect: See footnote)
Common Stock
Footnotes (4)
- [F1]Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on February 1, 2022.
- [F2]The shares are held in the name of the Eric Ostertag Living Trust dated March 30, 2016, of which the reporting person is the sole trustee.
- [F3]The shares are held in the name of Twin Prime Investments, an entity wholly owned by the reporting person.
- [F4]The shares are held in the name of the Ostertag Family Trust dated March 30, 2016, of which the reporting person is a trustee.